PT Merck Tbk (MERK.JK)
IDR 3500.0
(0.0%)
IDR 3500.0
(0.0%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 200.74 Billion IDR | 0.87% |
| 2022 | 190.57 Billion IDR | -8.04% |
| 2021 | 207.23 Billion IDR | 12.92% |
| 2020 | 183.53 Billion IDR | -6.5% |
| 2019 | 196.29 Billion IDR | 18.57% |
| 2018 | 165.55 Billion IDR | -56.62% |
| 2017 | 381.64 Billion IDR | 16.51% |
| 2016 | 327.55 Billion IDR | 5.63% |
| 2015 | 310.09 Billion IDR | 20.24% |
| 2014 | 257.89 Billion IDR | -18.56% |
| 2013 | 316.67 Billion IDR | 11.35% |
| 2012 | 284.4 Billion IDR | -1.02% |
| 2011 | 287.32 Billion IDR | 0.1% |
| 2010 | 287.04 Billion IDR | 21.54% |
| 2009 | 236.17 Billion IDR | 6.71% |
| 2008 | 221.32 Billion IDR | 13.86% |
| 2007 | 194.39 Billion IDR | 17.6% |
| 2006 | 165.29 Billion IDR | 24.57% |
| 2005 | 132.69 Billion IDR | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q3 | 49.19 Billion IDR | -4.5% |
| 2024 Q2 | 51.79 Billion IDR | 12.08% |
| 2024 Q1 | 46.2 Billion IDR | -13.56% |
| 2023 FY | 192.24 Billion IDR | 0.87% |
| 2023 Q4 | 53.45 Billion IDR | -9.01% |
| 2023 Q3 | 58.75 Billion IDR | 38.77% |
| 2023 Q2 | 42.33 Billion IDR | -1.38% |
| 2023 Q1 | 42.92 Billion IDR | -33.43% |
| 2022 Q3 | 45.4 Billion IDR | 17.93% |
| 2022 Q2 | 38.5 Billion IDR | -8.73% |
| 2022 Q1 | 42.18 Billion IDR | -40.92% |
| 2022 FY | 190.57 Billion IDR | -8.04% |
| 2022 Q4 | 64.48 Billion IDR | 42.02% |
| 2021 FY | 207.23 Billion IDR | 12.92% |
| 2021 Q1 | 39.92 Billion IDR | -34.09% |
| 2021 Q2 | 51.04 Billion IDR | 27.84% |
| 2021 Q3 | 44.86 Billion IDR | -12.11% |
| 2021 Q4 | 71.4 Billion IDR | 59.15% |
| 2020 FY | 183.53 Billion IDR | -6.5% |
| 2020 Q2 | 39.61 Billion IDR | -1.66% |
| 2020 Q4 | 60.58 Billion IDR | 40.69% |
| 2020 Q1 | 40.27 Billion IDR | -25.25% |
| 2020 Q3 | 43.05 Billion IDR | 8.7% |
| 2019 FY | 196.29 Billion IDR | 18.57% |
| 2019 Q1 | 39.59 Billion IDR | 133.37% |
| 2019 Q2 | 53.25 Billion IDR | 34.5% |
| 2019 Q3 | 49.57 Billion IDR | -6.91% |
| 2019 Q4 | 53.88 Billion IDR | 8.69% |
| 2018 Q3 | 91.31 Billion IDR | 1.34% |
| 2018 Q2 | 90.1 Billion IDR | -12.34% |
| 2018 FY | 165.55 Billion IDR | -56.62% |
| 2018 Q1 | 102.78 Billion IDR | -11.6% |
| 2018 Q4 | -118.65 Billion IDR | -229.93% |
| 2017 Q2 | 87.12 Billion IDR | -0.82% |
| 2017 FY | 381.64 Billion IDR | 16.51% |
| 2017 Q4 | 116.27 Billion IDR | 28.61% |
| 2017 Q3 | 90.4 Billion IDR | 3.77% |
| 2017 Q1 | 87.84 Billion IDR | 9.12% |
| 2016 FY | 327.55 Billion IDR | 5.63% |
| 2016 Q1 | 79.37 Billion IDR | -0.94% |
| 2016 Q2 | 92.35 Billion IDR | 16.35% |
| 2016 Q3 | 75.31 Billion IDR | -18.45% |
| 2016 Q4 | 80.5 Billion IDR | 6.88% |
| 2015 Q1 | 78.97 Billion IDR | 228.1% |
| 2015 Q2 | 83.43 Billion IDR | 5.66% |
| 2015 Q3 | 67.55 Billion IDR | -19.04% |
| 2015 Q4 | 80.13 Billion IDR | 18.61% |
| 2015 FY | 310.09 Billion IDR | 20.24% |
| 2014 FY | 257.89 Billion IDR | -18.56% |
| 2014 Q1 | 76.61 Billion IDR | -12.42% |
| 2014 Q2 | 82.25 Billion IDR | 7.36% |
| 2014 Q4 | 24.06 Billion IDR | -67.89% |
| 2014 Q3 | 74.95 Billion IDR | -8.87% |
| 2013 FY | 316.67 Billion IDR | 11.35% |
| 2013 Q4 | 87.48 Billion IDR | 12.31% |
| 2013 Q3 | 77.89 Billion IDR | -6.82% |
| 2013 Q2 | 83.59 Billion IDR | 23.48% |
| 2013 Q1 | 67.7 Billion IDR | -1.23% |
| 2012 Q2 | 72.86 Billion IDR | 11.0% |
| 2012 Q4 | 68.55 Billion IDR | -11.37% |
| 2012 FY | 284.4 Billion IDR | -1.02% |
| 2012 Q1 | 65.64 Billion IDR | 9.16% |
| 2012 Q3 | 77.34 Billion IDR | 6.14% |
| 2011 FY | 287.32 Billion IDR | 0.1% |
| 2011 Q3 | 71.87 Billion IDR | -15.23% |
| 2011 Q2 | 84.78 Billion IDR | 19.44% |
| 2011 Q1 | 70.98 Billion IDR | -1.85% |
| 2011 Q4 | 60.13 Billion IDR | -16.33% |
| 2010 Q4 | 72.32 Billion IDR | 0.0% |
| 2010 FY | 287.04 Billion IDR | 21.54% |
| 2010 Q1 | 58.76 Billion IDR | -26.9% |
| 2009 FY | 236.17 Billion IDR | 6.71% |
| 2009 Q4 | 80.39 Billion IDR | 0.0% |
| 2009 Q1 | 43.19 Billion IDR | 0.0% |
| 2008 FY | 221.32 Billion IDR | 13.86% |
| 2007 FY | 194.39 Billion IDR | 17.6% |
| 2006 FY | 165.29 Billion IDR | 24.57% |
| 2005 FY | 132.69 Billion IDR | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| PT Darya-Varia Laboratoria Tbk | 762.07 Billion IDR | 73.658% |
| PT Phapros, Tbk | 428.44 Billion IDR | 53.146% |
| PT Pyridam Farma Tbk | 293.43 Billion IDR | 31.589% |
| PT Industri Jamu dan Farmasi Sido Muncul Tbk | 827.82 Billion IDR | 75.751% |
| PT Tempo Scan Pacific Tbk | 3255.8 Billion IDR | 93.834% |